Drugs of Heparin derivatives are import anticoagulants (direct anticoagulant), of which low molecular weight heparin sodium and low molecular weight heparin calcium are the mainstream products. In global market key brands include: Pfizer's "Fragmin", Sanofi-Avetnis's "Clexane" and "Fraxiparine" etc.
The report presents the market size and development trend of Heparin derivatives, the sales values of different products, competitive manufacturers in China. The report also provides market forecasts and competitive and opportunity analysis in China.
The table of contents
1、Summary
2、Overview of blood thinning drugs
2.1 Anticoagulant Drugs
2.2 Antiplatelet drugs
2.3 Others of Anticoagulant or Antiplatelet drugs
2.4 Thrombolysis drugs
3 Sales analysis of blood thinning drugs in the past 4 years
3.1 Market scale and growth trend
3.2 Market share and change trend
3.2.1 Sales shares of different products of Blood Thinning Drugs
3.2.2 Sales shares of different products of Antiplatelet drugs
3.2.3 Sales shares of different products of Anticoagulant Drugs
3.2.4 Sales shares of different products of Thrombolysis drugs
3.3 Change about sales rank of key brands
4 Market analysis of Heparin derivatives in 2005
4.1 Sales situation Heparin derivatives and other blood thinning drugs in 2005
4.2 Market shares of different categories of blood thinning drugs in 2005
4.3 Analysis about key manufacturers
Low molecular weight heparin sodium
Low molecular weight heparin calcium
Heparin sodium
Heparin calium
5 Sales analysis of Heparin derivatives
6 Situation on global new drug research of blood thinning drugs
6.1 Antiplatelet drugs
6.2 Anticoagulant Drugs
7 Research and development in China
7.1 List of Domestic marketd products and import procucts
7.2 Status of application and approval for Blood Thinning Drugs
中文
